Health Care

There are 866,000 Louisianans without health insurance and 1.2 million on the Medicaid rolls receiving limited access to care.  The President’s health care law has hurt Louisiana families causing premiums to skyrocket and 93,000 Louisianans to lose their current health plan.  Unfortunately Obamacare is not making good on its promises to lower cost and increase access for all.  We must do all that we can to shield the American people from the devastating impact of limited access to health care providers, limited choices in the market place, and higher costs.

Here are some of the steps I have taken to improve our health care system:

I was the first U.S. Senator to call for a vote on the full repeal of Obamacare.

Supporting increased competition in the marketplace to lower costs by allowing consumers to purchase health insurance across state lines.

Improving flexibility and expanding health care choices by encouraging patients to use health savings accounts (HSAs) and flexible spending accounts (FSAs) to purchase goods and utilize health care services that meet their individual medical needs.

Authoring legislation to allow the reimportation of safe, affordable prescription drugs from Canada and other countries to lower cost of medications.

Authoring legislation to expedite the approval of generic drugs so Louisianans can buy cheaper versions of FDA-approved prescription drugsEnsuring all of Louisiana’s children have access to quality health care.

Authored legislation to create tax relief for seniors in need of special services.

Voted to make health care premiums 100 percent tax-deductible and

Fighting frivolous lawsuits that are driving doctors out of business and increasing costs for patients.

 U.S. Department of Health and Human Services

U.S. Senate Committee on Health, Education, Labor, and Pensions

Centers for Medicare and Medicaid Services

Food and Drug Administration

Centers for Disease Control

National Institutes of Health


Latest

  • Vitter Introduces Bill to Protect Access to Life-Saving Medications

    (Washington, D.C.) - U.S. Senator David Vitter (R-La.) today announced that he has introduced legislation to protect and expand access to life-saving compounded medications. Compounded medications are used to treat patients with unique medical conditions that make them resistant to standard medications, such as pediatric cancer patients. Vitter’s legislation, the Saving Access to Compounded Medications for Special Needs Patients Act, would ensure that patients have access to the custom medications they need.

     Read More


  • House Committee Passes Vitter’s Steve Gleason Act

    (Washington, D.C.) - U.S. Senator David Vitter (R-La.) today announced that the Ways and Means Committee in the U.S. House of Representatives has passed his Steve Gleason Act. The legislation is expected to get a vote before the full House of Representatives this month. Vitter’s legislation will make speech generating devices (SGDs) more accessible, helping patients diagnosed with diseases such as Amyotrophic lateral sclerosis (ALS), live more independent lives.

     Read More


  • Vitter: Steve Gleason Act to Get House Vote in June

    (Washington, D.C.) - U.S. Sen. David Vitter (R-La.) today announced that he has received confirmation from leadership in the U.S. House of Representatives that they will bring Vitter’s Steve Gleason Act up for a vote in June. The House Ways and Means Committee is expected to markup Vitter’s legislation on June 2, and will likely get a vote in the full house shortly after that.

     Read More


  • Vitter, Heitkamp, McMorris Rodgers, Wasserman Schultz Urge HHS to Protect Access to Breast Cancer Screenings

    (Washington, D.C.) - U.S. Senators David Vitter (R-La.) and Heidi Heitkamp (D-N.D.), along with Congresswomen Cathy McMorris Rodgers (R-Wash.) and Debbie Wasserman Schultz (D-Fla.), today led a bipartisan, bicameral group of 62 Members of Congress in calling on the Department of Health and Human Services (HHS) to oppose recommendations from the United States Preventive Services Task Force (USPSTF) that would make it more difficult for women to receive annual breast cancer screenings.

     Read More


  • Vitter Announces Encouraging Step Forward on Team Gleason Efforts

    (Washington, D.C.) - U.S. Senator David Vitter (R-La.) today announced that the Center for Medicare & Medicaid Services (CMS) is updating its Medicare coverage policy on speech-generating devices (SGDs), which addresses some of the issues mentioned in a bipartisan, bicameral letter sent last fall. The new CMS policy would finally allow patients to “unlock” devices and use communication tools like email and text message. Similar equipment is used by Steve Gleason, former professional football player with the New Orleans Saints. Vitter recently passed the Steve Gleason Act through the Senate. It awaits a vote in the House of Representatives.

     Read More


  • Vitter Announces Bipartisan-Supported TSCA Reform Passes Through EPW Committee

    ( Sen. David Vitter (R-La.) today announced that the Frank R. Lautenberg Chemical Safety for the 21st Century Act passed through the Environment and Public Works (EPW) Committee. The vote was 15 yeas to 5 nays, with all 11 Republicans and 4 Democrats voting in favor of the legislation. The Lautenberg Chemical Safety Act will enact common-sense reforms that are necessary to update the United States’ ineffective, outdated chemical regulatory program.

     Read More


  • Vitter Gets Major Victory for Team Gleason, ALS Patients

    (Washington, D.C.) - U.S. Senator David Vitter (R-La.) today announced that the U.S. Senate has unanimously passed his bipartisan legislation, the Steve Gleason Act of 2015. Vitter’s legislation will make speech generating devices (SGDs) more accessible, helping patients diagnosed with diseases such as Amyotrophic lateral sclerosis (ALS) live more independent lives. 

     Read More


  • Vitter, Manchin Introduce Legislation to Hold FDA Accountable for Approving Dangerous, Addictive Drugs

    (Washington, D.C.) - U.S. Senators David Vitter (R-La.) and Joe Manchin (D-W.Va.) today introduced the FDA Accountability for Public Safety Act, which would hold the Food and Drug Administration (FDA) accountable for opioid drugs approved by the agency. The legislation would ensure that experts’ voices are heard when the FDA is considering new, dangerous opioid medications.

     Read More


  • Print
  • Email